col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Journal of Clinical Hypertension
  original article Date Title Authors   All Authors
1 [GO] 2021―Jun―25 Risk factors for the delayed viral clearance in COVID-19 patients Xiaoping Chen, Wenjia Hu MT, Miao Yang, Jiaxin Ling, Yongxi Zhang, Liping Deng, et al. (+4)
2 [GO] 2021―May―06 Arterial stiffness and COVID-19: A bidirectional cause-effect relationship Sahrai Saeed, Giuseppe Mancia
3 [GO] 2021―Feb―15 Advancing hypertension management in Asia 2021, beyond COVID-19 Aletta E. Schutte
4 [GO] 2021―Feb―03 Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic Keisuke Narita, Satoshi Hoshide, Kelvin Tsoi, Saulat Siddique, Jinho Shin, Yook-Chin Chia, et al. (+9)
5 [GO] 2021―Jan―25 Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19 Jacques Amar, Nicolas Touront, Antoine M. Ciron, Caroline Pendaries
6 [GO] 2020―Dec―25 The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges? Marijana Tadic, Cesare Cuspidi
7 [GO] 2020―Dec―25 Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? Martin R. Salazar
8 [GO] 2020―Dec―25 Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital Yuhui Sun, Xizhou Guan, Lijing Jia, Ning Xing, Liuquan Cheng, Bo Liu, et al. (+2)
9 [GO] 2020―Nov―21 Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study Ann Z. Bauer, Rebecca Gore, Susan R. Sama, Richard Rosiello, Lawrence Garber, Devi Sundaresan, et al. (+3)
10 [GO] 2020―Oct―25 COVID-19 and cardiovascular risk: Flying toward a silent world? Frédéric Dutheil, Julien S. Baker, Valentin Navel
11 [GO] 2020―Oct―02 Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension Renzheng Chen, Jie Yang, Xubin Gao, Xiaohan Ding, Yuanqi Yang, Yang Shen, et al. (+11)
12 [GO] 2020―Sep―20 COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved? Marijana Tadic, Cesare Cuspidi
13 [GO] 2020―Sep―16 Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol Jordana B. Cohen, Thomas C. Hanff, Vicente Corrales-Medina, Preethi William, Nicolas Renna, Nelson R. Rosado-Santander, et al. (+21)
14 [GO] 2020―Sep―03 Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation Christina Antza, Stella Stabouli
15 [GO] 2020―Aug―28 Increased cardiovascular death rates in a COVID-19 low prevalence area Rita Del Pinto, Claudio Ferri, Leondino Mammarella, Stefano Abballe, Sofia Dell'Anna, Sabrina Cicogna, et al. (+3)
16 [GO] 2020―Jul―25 Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain Angel Vila-Corcoles, Eva Satue-Gracia, Olga Ochoa-Gondar, Cristina Torrente-Fraga, Frederic Gomez-Bertomeu, Angel Vila-Rovira, et al. (+5)
17 [GO] 2020―Jul―09 COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network Kazuomi Kario, Yuji Morisawa, Apichard Sukonthasarn, Yuda Turana, Yook-Chin Chia, Sungha Park, et al. (+5)
18 [GO] 2020―Jul―06 COVID-19 and arterial hypertension: Hypothesis or evidence? Marijana Tadic, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia
19 [GO] 2020―May―30 COVID-19 and diabetes: Is there enough evidence? Marijana Tadic, Cesare Cuspidi, Carla Sala


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec